THBD and acute myeloid leukemia: This was resolved recently by Hsu et al. who utilized a stringent flow cytometry gating strategy with extra lineage and cDC-specific markers to eliminate leukemic blasts and concluded to a dramatic decrease in the blood CD141+ cDC1 and CD1c+ cDC2 subsets at AML diagnosis [34].